Clinical reference Biomarker Directory
Back to directory

CRP

Established

CRP is a general inflammation marker; its high-sensitivity form is now recommended for cardiovascular risk assessment.

Also known as hsCRP high-sensitivity C-reactive protein
In plain language

CRP rises whenever the body is inflamed, whether from infection or heart disease risk. A more sensitive version of the test is now recommended alongside cholesterol testing to help doctors assess heart disease risk more completely.

Biomarker & context

C-reactive protein (CRP) is an acute-phase protein produced by the liver in response to inflammatory cytokines (especially IL-6), serving as a general, nonspecific marker of inflammation, infection, and tissue injury.

What it indicates

Elevated CRP indicates systemic inflammation from infection, autoimmune flare, or tissue injury; a high-sensitivity version (hsCRP) is used specifically for cardiovascular risk assessment, since it can detect low-grade inflammation linked to atherosclerosis.

Diagnosis & clinical testing

The American College of Cardiology issued a 2025 scientific statement recommending routine hsCRP measurement alongside lipid panels for cardiovascular risk assessment in both primary and secondary prevention. Standard risk tiers: <1 mg/L low risk, 1-3 mg/L average, >3 mg/L high risk (roughly double the cardiovascular event rate); two separate measurements two weeks apart, averaged, are recommended for risk stratification given CRP's real biological variability.

Guiding treatment

In cardiology, persistently elevated hsCRP despite target LDL cholesterol identifies patients with "residual inflammatory risk" who may benefit from anti-inflammatory therapy considerations; in general medicine, serial CRP tracks response to infection or inflammatory disease treatment.

Clinical significance

2025 ACC guidance expands its role in routine cardiovascular prevention alongside lipid testing.

References
  1. ACC. (2025). Scientific Statement on hsCRP in Cardiovascular Risk Assessment.
  2. JACC. (2016). A Test in Context: High-Sensitivity C-Reactive Protein.